España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MiMedx Group
MDXG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.98
0.13
1.66%
At close: -
$7.98
0.00
0.00%
After Hours: Feb 21, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 3 days from now on Wed Feb 26th, after the market close
Conference call scheduled in 3 days at 16:30 PM
Click to view the webcast
MiMedx Group (MDXG) Forecast
News
Earnings
MiMedx Group (MDXG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MiMedx Group (NASDAQ:MDXG) Stock
MiMedx Group Stock (NASDAQ: MDXG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 29, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, January 27, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, January 17, 2025
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, December 17, 2024
MIMEDX Files Patent Infringement Lawsuit Agai...
Benzinga Newsdesk
Thursday, November 14, 2024
MiMedx Group shares are trading higher after ...
Benzinga Newsdesk
MiMedx Group Provides Update On Local Coverag...
Benzinga Newsdesk
Thursday, October 31, 2024
MiMedx Group shares are trading higher after ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, October 30, 2024
MiMedx Group Q3 2024 Adj. EPS $0.07 Beats $0....
Benzinga Newsdesk
Thursday, August 01, 2024
Cantor Fitzgerald Reiterates Overweight on Mi...
Benzinga Newsdesk
Craig-Hallum Maintains Buy on MiMedx Group, L...
Benzinga Newsdesk
Wednesday, July 31, 2024
MIMEDX Expects 2024 Net Sales Growth In Mid-T...
Benzinga Newsdesk
MiMedx Group shares are trading lower after t...
Benzinga Newsdesk
MiMedx Group Announces Commercial Launch Of H...
Benzinga Newsdesk
MiMedx Group Q2 2024 Adj. EPS $0.08, Inline, ...
Benzinga Newsdesk
Monday, July 22, 2024
MiMedx Publishes First Study In Top Journal H...
Benzinga Newsdesk
Tuesday, July 02, 2024
Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes
Vandana Singh
Cantor Fitzgerald Initiates Coverage On MiMed...
Benzinga Newsdesk
Wednesday, May 01, 2024
MiMedx Group shares are trading higher after ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MiMedx ...
Benzinga Newsdesk
Tuesday, April 30, 2024
MiMedx Group Q1 2024 Adj EPS $0.07 Beats $0.0...
Benzinga Newsdesk
Wednesday, March 27, 2024
The FDA Issued Determination Letter For Mimed...
Benzinga Newsdesk
Wednesday, March 20, 2024
Tela Bio Announced Sale Of Distribution Right...
Benzinga Newsdesk
Thursday, March 07, 2024
Lake Street Initiates Coverage On MiMedx Grou...
Benzinga Newsdesk
Friday, March 01, 2024
Mizuho Maintains Buy Rating for MiMedx Group: Here's What You Need To Know
Benzinga Insights
Mizuho Maintains Buy on MiMedx Group, Raises ...
Benzinga Newsdesk
Wednesday, February 28, 2024
MiMedx Group Sees FY24 Adj. EBITDA As A Perce...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
MiMedx Group Q4 2023 Adj EPS $0.04 Misses $0....
Benzinga Newsdesk
Recap: MiMedx Group Q4 Earnings
Benzinga Insights
Earnings Scheduled For February 28, 2024
Benzinga Insights
Monday, January 22, 2024
MiMedx Enhanced Its Capital Structure By Refi...
Benzinga Newsdesk
Tuesday, January 02, 2024
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor
MiMedx shares are trading lower after the com...
Benzinga Newsdesk
Friday, December 29, 2023
MIMEDX Announces Receipt Of FDA Warning Lette...
Bill Haddad
Thursday, December 28, 2023
MiMedx Group Says Its Outstanding 95,000 Shar...
Benzinga Newsdesk
Thursday, November 02, 2023
MIMEDX To Highlight Published Data At SAWC Fa...
Benzinga Newsdesk
Tuesday, October 31, 2023
Mizuho Maintains Buy on MiMedx Group, Lowers ...
Benzinga Newsdesk
Monday, October 30, 2023
MiMedx Group Q3 2023 Adj EPS $0.05 Beats $0.0...
Benzinga Newsdesk
Earnings Scheduled For October 30, 2023
Benzinga Insights
Friday, October 27, 2023
Craig-Hallum Initiates Coverage On MiMedx Gro...
Benzinga Newsdesk
MiMedx Group's Earnings: A Preview
Benzinga Insights
Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday
Lisa Levin
Tuesday, August 15, 2023
MediWound Announces Collaboration With MIMEDX On EscharEx Phase III Study
Happy Mohamed
Wednesday, August 02, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Mizuho Maintains Buy on MiMedx Group, Raises ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on MiMedx G...
Benzinga Newsdesk
Tuesday, August 01, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
